Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-01-01 @ 11:19 PM
Study NCT ID:
NCT05286567
Status:
COMPLETED
Last Update Posted:
2023-01-31
First Post:
2022-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.
Sponsor:
Aarhus University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-29
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-10
First Submit QC Date:
None
Study First Post Date:
2022-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-30
Last Update Post Date:
2023-01-31
Last Update Post Date Type:
ACTUAL